References
- Bove J. R., Ebaugh F. G. The use of diiso-propylfluorophosphate32 for the determination of in vivo red cell survival and plasma cholinestrase turnover rates. J. Lab. clin. Med. 1958; 51: 916
- Cline M. J., Berlin N. The red cell chromium elution rate in patients with some hematologic diseases. Blood 1961; 21: 63
- Cline M. J., Berlin N. Simultaneous measurement of the survival of two populations of erythrocytes with the use of labelled diisopropylfluoro-phosphate. J. Lob. clin. Med. 1963; 61: 249
- Cohen J. A., Warringa M. G. P.J. The fate of P32 labelled diisopropylfluorophosphonate in the human body and its use as a labelling agent in the study of the turnover of blood plasma and red cells. J. clin. Invest. 1954; 33: 459
- Eadie G. S., Smith W. W., Brown J. W., Jr. The use of DFP32 as a red cell tag with and without simultaneous tagging with chromium51 in certain animals in the presence or absence of random destruction. J. gen. Physiol. 1960; 4: 825
- Garby L. Analysis of red-cell survival curves in clinical practice and the use of di-iso-propylfluoro-phosphonate (DF32P) as a label for red cells in man. Brit. J. Haemat. 1962; 8: 15
- Garby L., Hjelm M. Short term assessment of red cell survival with an improved Cr51 technique. Scand. J. clin. Lab. Invest. 1962; 14: 581
- Hjort P. F., Paputschis H., Cheney B. Labeling of red blood cells with radioactive diisopro-pylfluorophosphate (DF32P): evidence for an initial release of label. J. Lab. clin. Med. 1960; 55: 416
- Mollison P. L. Further observations on the normal survival curve of 51Cr-labelled red cells. Clin. Sci. 1961; 21: 21
- Mollison P. L. Blood Transfusion in Clinical Medicine3rd ed. Blackwell Scientific Publications, Oxford 1961
- Wadman B., To be published.